![Identification of SR8278, a Synthetic Antagonist of the Nuclear Heme Receptor REV-ERB | ACS Chemical Biology Identification of SR8278, a Synthetic Antagonist of the Nuclear Heme Receptor REV-ERB | ACS Chemical Biology](https://pubs.acs.org/cms/10.1021/cb1002575/asset/images/large/cb-2010-002575_0005.jpeg)
Identification of SR8278, a Synthetic Antagonist of the Nuclear Heme Receptor REV-ERB | ACS Chemical Biology
![Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial - The Lancet Respiratory Medicine Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/a1f060f4-7806-40bf-839a-56ef24f6f8d6/gr1.gif)
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial - The Lancet Respiratory Medicine
![New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction - ScienceDirect New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253820312345-fx1.jpg)
New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction - ScienceDirect
![Molecules | Free Full-Text | A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia Molecules | Free Full-Text | A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia](https://pub.mdpi-res.com/molecules/molecules-27-06041/article_deploy/html/images/molecules-27-06041-g001.png?1663322109)
Molecules | Free Full-Text | A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia
![Stimulation of the Locus Ceruleus Modulates Signal-to-Noise Ratio in the Olfactory Bulb | Journal of Neuroscience Stimulation of the Locus Ceruleus Modulates Signal-to-Noise Ratio in the Olfactory Bulb | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/37/48/11605/F1.large.jpg)
Stimulation of the Locus Ceruleus Modulates Signal-to-Noise Ratio in the Olfactory Bulb | Journal of Neuroscience
![Agonist-antagonist muscle strain in the residual limb preserves motor control and perception after amputation | Communications Medicine Agonist-antagonist muscle strain in the residual limb preserves motor control and perception after amputation | Communications Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43856-022-00162-z/MediaObjects/43856_2022_162_Fig1_HTML.png)
Agonist-antagonist muscle strain in the residual limb preserves motor control and perception after amputation | Communications Medicine
![IJMS | Free Full-Text | GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis? IJMS | Free Full-Text | GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis?](https://pub.mdpi-res.com/ijms/ijms-22-11342/article_deploy/html/images/ijms-22-11342-g001.png?1634736310)
IJMS | Free Full-Text | GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis?
![Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects | Nature Reviews Nephrology Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41581-021-00490-8/MediaObjects/41581_2021_490_Fig1_HTML.png)
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects | Nature Reviews Nephrology
![Abnormal center of mass control during balance: a new biomarker of falls in people with Parkinson's disease | bioRxiv Abnormal center of mass control during balance: a new biomarker of falls in people with Parkinson's disease | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/01/11/2020.01.27.921379/F2.large.jpg)
Abnormal center of mass control during balance: a new biomarker of falls in people with Parkinson's disease | bioRxiv
![Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial - The Lancet Respiratory Medicine Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/35f94457-9b33-4a76-9cb4-4153f6cf4a34/gr1.jpg)
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial - The Lancet Respiratory Medicine
![JCM | Free Full-Text | Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist JCM | Free Full-Text | Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist](https://www.mdpi.com/jcm/jcm-12-03992/article_deploy/html/images/jcm-12-03992-g001-550.jpg)